Finance

Beta
Lists
300878:SHE
Zhejiang Wecome Pharmaceutical Co Ltd
CNÂ¥28.79
-0.24%
(-0.070) 1D
Jun 5, 3:04:16 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300878...
Open
CNÂ¥28.92
High
CNÂ¥29.70
Low
CNÂ¥28.44
Mkt. cap
4.18B
Avg. vol.
3.83M
Volume
2.14M
52-wk high
CNÂ¥37.11
52-wk low
CNÂ¥15.22
EPS
-CNÂ¥1.49
Shares outstanding
144.79M
No. of employees
535
Open
CNÂ¥28.92
High
CNÂ¥29.70
Low
CNÂ¥28.44
Mkt. cap
4.18B
Avg. vol.
3.83M
Volume
2.14M
52-wk high
CNÂ¥37.11
52-wk low
CNÂ¥15.22
EPS
-CNÂ¥1.49
Shares outstanding
144.79M
No. of employees
535
News stories
From sources across the web
About Zhejiang Wecome Pharmaceutical Co Ltd
CEO-
Employees535
FoundedMar 31, 2000
Headquarters-
SectorPharmaceutical industry
Websitezjwk.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
44.79M
36.75M
73.95M
69.66M
Cost of goods sold
60.67M
33.52M
27.19M
28.21M
Cost of revenue
60.67M
33.52M
27.19M
28.21M
Research and development expenses
3.32M
1.67M
1.71M
2.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
33.45M
31.87M
42.25M
26.23M
Operating expense
34.73M
27.62M
53.89M
28.53M
Total operating expenses
95.40M
61.14M
81.08M
56.74M
Operating income
-50.61M
-24.39M
-7.12M
12.92M
Other non operating income
-181.73K
-29.48K
-13.71M
-6.96M
EBT including unusual items
-54.07M
-55.73M
-96.46M
5.72M
EBT excluding unusual items
-52.28M
-26.03M
-16.28M
6.22M
Income tax expense
539.65K
3.78M
9.45M
3.88M
Effective tax rate
-1.00%
-6.78%
-9.79%
67.78%
Other operating expenses
-12.22K
-3.99M
1.10M
221.88K
Net income
-54.37M
-59.63M
-103.49M
1.74M
Net profit margin
-121.37%
-162.28%
-139.93%
2.50%
Earnings per share
-
-
-
-
Interest and investment income
360.80K
260.87K
5.66M
263.57K
Interest expense
-1.85M
-1.88M
-1.11M
-
Net interest expenses
-1.49M
-1.62M
4.55M
263.57K
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.18M
-9.82M
8.60M
28.64M
Gain or loss from assets sale
493.86K
-493.86K
992.60K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer